Save to favorites
This feature is restricted to active members.
Join now to save favorites and get all member benefits, including over 1,400 reviews.
Join NowAlready a member? Sign in here.
Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted November 07, 2024
Sexual Enhancement Supplements Sold on Amazon Recalled
On November 4, 2024, four sexual enhancement supplements sold on Amazon and other websites, ZoomMax and ZapMax (Boulla LLC) and VitalityXtra and PeakMax (VitalityVita LLC) were recalled because they were found to contain undeclared prescription drugs, sildenafil and diclofenac.
(See ConsumerLab's Sexual Enhancer Supplements Review for tests of related products.)
Sildenafil (the active ingredient in Viagra) may cause symptoms like headache and flushing and can interact with medications containing nitrates such as nitroglycerine, resulting in dangerously low blood pressure.
Diclofenac is a prescription non-steroidal anti-inflammatory drug (NSAID) that can cause serious cardiovascular events such as heart attack or stroke, as well as bleeding, ulceration, and fatal tears of the stomach and intestines, or liver toxicity. Diclofenac may also interact with other medications and significantly increase the risk of adverse events.
ZoomMax and ZapMax capsules were distributed at VitalityVita.com nationwide in the USA. VitalityXtra and PeakMax capsules were distributed on Amazon.com in the USA.
The supplements were labeled as containing a combination of herbs such as thailand butea superba, tribulus terrestris, epimedium root, maca, tongkat ali, and ginseng. More details about the recalled products, including affected lot numbers, are listed below (use the links to read the full warning letter and see product photos).
- VitalityVita LLC (VitalityXtra and PeakMax) are packaged in 10-count blister packs. VitalityXtra is packaged in a green, yellow, and white carton and PeakMax is packaged in a purple, yellow, and white carton. Both products are labeled with Lot#: 230811 and an expiration date of 8/11/25 (see product photos).
- Boulla LLC (ZoomMax and ZapMax) are packaged in 10-count blisters packs. ZoomMax is packaged in an orange and white carton and ZapMax is packaged in a purple and white carton. Both prodcuts are labeled with Lot#: YZM240406 and an expiration date of 04/05/27 (see product photos).
Consumers that have ZoomMax and ZapMax capsules or VitalityXtra and PeakMax capsules should stop use immediately and contact their physician or healthcare provider if they have experienced any problems that may relate to taking or using this product. Consumers and or healthcare providers are advised to report any adverse reactions to the FDA MedWatch Voluntary Reporting Program by fax, mail, or online.
For more information, use the links below.
See related recalls and warnings:
Two Sexual Enhancement Supplements Sold on Amazon Recalled
Three Male Enhancement Products Recalled Due to Undeclared Drugs
Three Sexual Enhancement Supplements Sold on Amazon Recalled
Eleven Brands of Sexual Enhancement Supplements Recalled Due to Undeclared Prescription Drugs
Report a Problem
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem. Please select from one of these options:
Dietary Supplement or Nutritional Product Problem Report
If you believe that a dietary supplement (e.g., vitamin, mineral, or herbal supplement) or other nutritional product has caused an unexpected, adverse reaction, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their Safety Reporting Portal at https://www.safetyreporting.hhs.gov.
Please complete the form below as accurately as possible. You may need to check the label on the product.
Thank you for submitting your report.
Generic Drug Problem Report
If you believe that a generic drug has not acted like the original drug, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their MedWatch program at the FDA MedWatch website.
Please complete the form below as accurately as possible. You may need to check the label on the drug.
Thank you for submitting your report.
